Skip to main content
. 2016 Jan 25;7(6):7307–7317. doi: 10.18632/oncotarget.7007

Figure 6. Inhibition of stemness and EMT by IL-32θ.

Figure 6

The stemness of HT29 cells and EMT were inhibited by IL-32θ via inhibition of the STAT3-ZEB1 pathway and subsequent regulation of downstream factors.